In an accompanying report, we showed that viridans group streptococci may prevent methicillin-resistant Staphylococcus aureus (MRSA) colonization of the oral cavities of newborns. In the present study, we investigated the mechanism of prevention in vitro. Most viridans group streptococci had bacteriocin-like activity and killed MRSA, Burkholderia cepacia, Enterobacter aerogenes, and Pseudomonas aeruginosa; however, Escherichia coli, Enterobacter cloacae, and Candida albicans were resistant. The activity was induced only by H 2 O 2 -secreting strains and was inhibited by horseradish peroxidase or catalase in a dose-dependent manner. Despite extensive prevention efforts, infection or colonization by methicillin-resistant Staphylococcus aureus (MRSA) is a serious problem in neonatal intensive care units [1] [2] [3] . Moreover, emergence of strains resistant to mupirocin [4, 5] and vancomycin [6] makes the situation more complicated.
In an accompanying report, we showed that viridans group streptococci may prevent methicillin-resistant Staphylococcus aureus (MRSA) colonization of the oral cavities of newborns. In the present study, we investigated the mechanism of prevention in vitro. Most viridans group streptococci had bacteriocin-like activity and killed MRSA, Burkholderia cepacia, Enterobacter aerogenes, and Pseudomonas aeruginosa; however, Escherichia coli, Enterobacter cloacae, and Candida albicans were resistant. The activity was induced only by Despite extensive prevention efforts, infection or colonization by methicillin-resistant Staphylococcus aureus (MRSA) is a serious problem in neonatal intensive care units [1] [2] [3] . Moreover, emergence of strains resistant to mupirocin [4, 5] and vancomycin [6] makes the situation more complicated.
The role of normal flora in preventing infectious diseases caused by many pathogenic microorganisms has been a fascinating subject for investigators, although only a few investigations were made in the 1990s. How-ever, in recent years, as the importance of limiting antibiotic use has been understood, investigators have been motivated to study the subject again [7] [8] [9] [10] , and some of them (including our group) have reported specific examples [9, 11] . H 2 O 2 and H 2 O 2 -producing normal flora are expected to protect against infectious diseases caused by many pathogens. Lactobacillus species producing H 2 O 2 are believed to protect pregnant women against vaginosis [7, 10] , and viridans group streptococci inhabiting oral cavities also have an antagonistic effect on many bacterial species [8, [12] [13] [14] . In an accompanying report [15] , we showed that viridans group streptococci colonizing oral cavities in newborns inhibit MRSA colonization. In this study, we analyze whether H 2 O 2 produced by viridans group streptococci really inhibits MRSA growth in vitro. 
MATERIALS AND METHODS

Microbiological testing.
All swab specimens obtained from newborns in Neonatal Intensive Care at Nagano Children's Hospital (Toyoshina, Japan) during the 26-month study period, from April 1995 through May 1997, were inoculated onto plates with 5% sheep blood agar, chocolate agar, modified Drigarsky agar, or OPA Staphylococcus agar (all plates were purchased from BBL Becton Dickinson Microbiology Systems), and the plates were incubated for 24 h at 37ЊC in 5% CO 2 in air. Bacterial identification and antibiotic susceptibility testing were performed by autoSCAN-4 (Dade Behring) and the conventional method as described elsewhere [16, 17] . MRSA was defined as S. aureus for which the oxacillin MIC was 14 mg/mL.
Assay of the bacteriocin-like activity of viridans group streptococci. S. aureus ( cfu of MRSA) in 100 mL of PBS 6 1 ϫ 10 was mixed with 10 mL of melting (at 37ЊC) brain-heart infusion broth medium (Nissui) with 1.5% low-melting-point (37ЊC) agar (Eastman Kodak) and poured into a -mm plastic 15 ϫ 100 dish (BBL Becton Dickinson Microbiology Systems). After solidification, the mixture was overlaid with 10 mL of the same medium without MRSA, to prevent direct contact between MRSA and viridans group streptococci, and the overlay was solidified (this overlay was omitted in some of the experiments). Suspensions of bacteria (various species of viridans group streptococci, Enterococcus faecalis, or Staphylococcus epidermidis; cfu) in 10 mL of PBS were spotted on the agar plate 7 1 ϫ 10 and incubated overnight at 37ЊC. In the control group, 10 mL of various dilutions of reagent H 2 O 2 was similarly spotted. After incubation, 10 mL of low-melting-point (37ЊC) agar was overlaid and stained with 0.04% crystal violet in both groups. Diameters of the zones of inhibition were measured. Five MRSA strains (N803, N810, N815, N822, and N830) were targeted. The activity of viridans group streptococci against S. epidermidis was measured in a similar manner. Bactericidal activity of viridans group streptococci against MRSA was also measured, using a 96-well micro-test plate. Various amounts of viridans group streptococci ( , , 5 6 1 ϫ 10 1 ϫ 10 , and cfu) were cocultured overnight at 37ЊC in 7 8 1 ϫ 10 1 ϫ 10 200 mL of brain-heart infusion broth medium with cfu Inhibition of bacteriocin-like activity by horseradish peroxidase or catalase. The inhibitory activity of horseradish peroxidase against the bacteriocin-like activity of viridans group streptococci was measured by the agar plate method described above, with a minor modification. Brain-heart infusion broth medium with low-melting-point (37ЊC) agar containing various amounts (0, 16, 80, 400, and 2000 mg/plate) of horseradish peroxidase was used as an overlay on solidified MRSA. The inhibitory activity of horseradish peroxidase against culture products of 4 different strains of viridans group streptococci isolated from newborns (S. gordonii, S. mitis, S. sanguinis, and S. oralis) was assayed. The inhibitory activity of catalase (from Aspergillus niger; Sigma) was assayed in a similar manner.
Determination of H 2 O 2 concentration in supernatant fluid of bacterial culture. Suspensions of bacteria (absorbance at 620 nm, 0.78) in 0.9% NaCl were prepared from overnight cultures of viridans group streptococci (20 strains) or enterococci (2 strains). In a 1.5-mL micro-test tube (Sarstedt), an aliquot of the suspension (100-mL aliquots, each containing cfu) was mixed with 100 mL of brain-heart infusion 8 ∼ 1 ϫ 10 broth medium and cultured at 37ЊC for 9 h. After incubation, 20 mL of supernatant fluid or a 1:2 serial dilution of supernatant fluid with PBS was mixed with 20 mL of horseradish peroxidase (0.5 mg/mL of PBS [pH 7.0]) and 50 mL of a solution of 0.1 mg of 3,3 ,5,5 -tetramethylbenzidine/mL of 0.05 M phosphate citrate buffer (pH 5.0) (Sigma) and incubated at room temperature for 1 min. Then, the enzymatic reaction was stopped by the addition of 100 mL of 2-M H 2 SO 4 , and color intensity was measured at 420 nm by the ELISA processor II (Dade Behring). Simultaneously, the bacteriocin-like activity of 10 mL of bacterial suspension ( cfu) was measured by the 7 ∼ 1 ϫ 10 agar plate method. Catalase activity. Catalase activity on the cell surface was measured as follows: 0.1 mL of bacterial suspension was added to 2.9 mL of substrate solution (0.1 mL of 30% H 2 O 2 to 50 produced by viridans group streptococci to inhibition of methicillin-resistant Staphylococcus aureus (MRSA) colonization of oral cavities in newborns. Brain-heart infusion broth medium with low-melting-point agar containing horseradish peroxidase was poured on solidified MRSA, and an overlay was made; viridans group streptococci were then spotted on it, and culture was performed. Viridans group streptococci killed MRSA and created zones of inhibition (0 mg of horseradish peroxidase/plate). However, horseradish peroxidase neutralized the activity and reduced the diameter of the zone of inhibition in a dose-dependent manner. mL of 0.05-M PBS, pH 7.0), and the time required for absorbance at 240 nm to decrease from 0.450 to 0.400 at 25ЊC was measured by the spectrophotometer CL 1200 (Shimadzu). One unit was defined as the activity decomposing 1.0 mmol of H 2 O 2 /min by cfu of bacteria at pH 7.0 at 25ЊC. 8 1 ϫ 10 Bacteriocin-like activity of viridans group streptococci in saliva. MRSA (∼50 cfu of N803) and various amounts of viridans group streptococci (clinical isolates of S. sanguinis, S. oralis, S. mitis, and S. gordonii) were mixed with 200 mL of saliva specimens from 3 healthy volunteers (specimens were disinfected by centrifugation 4 times at 16,000 g for 30 min) and were cultured (total culture volume, 300 mL) at 36ЊC for 15 h. MRSA survival and growth after incubation was enumerated with use of OPA staphylococcus media.
Statistical analysis.
Group data are expressed as , and differences between groups were analyzed by mean ‫ע‬ SD the paired Student's t test or the x 2 test. amount of viridans group streptococci necessary to completely kill 1 cfu of MRSA was 1500 cfu.
RESULTS
Bacteriocin
Inhibition of bacteriocin-like activity by horseradish peroxidase or catalase. Bacteriocin-like activity was inhibited by horseradish peroxidase or a catalase layer laid between viridans group streptococci and MRSA. The amount of horseradish peroxidase necessary for complete inhibition of the bacteriocinlike activity was directly proportional to the diameter of the zone of inhibition (figure 3). The concentration of horseradish peroxidase necessary for complete inhibition of the bacteriocinlike activity of cfu of viridans group streptococci was 7 1 ϫ 10 400 mg per plate, and even at this concentration the growth of MRSA and viridans group streptococci in the control cultures was never inhibited. Similarly, bacteriocin-like activity of viridans group streptococci and reagent H 2 O 2 was inhibited by catalase, and diameters of zones of inhibition were directly proportional to the catalase activity (figure 4). On figure 4, the line representing viridans group streptococci demonstrates the average of data for 4 different species (S. oralis, S. sanguinis, S. mitis, and S. gordonii). For complete inhibition of bacteriocinlike activity of viridans group streptococci, an extremely large amount of catalase was required (20 U/plate).
Catalase activity on cell surfaces and resistance to reagent H 2 O 2 . Several bacteria isolated from oral cavities of newborns were tested for their ability to resist reagent H 2 O 2 , and the relationship between resistance to H 2 O 2 and catalase activity on cell surfaces was studied. According to the mean diameter of the zones of , isolates were divided into 2 inhibition ‫ע‬ SD groups: those susceptible to H 2 Production of bacteriocin-like activity in saliva. All 4 species of viridans group streptococci had bacteriocin-like activity during 15-h cultures of saliva specimens. In the control culture, MRSA was grown, and its cell number increased from 50 to cfu, whereas growth of MRSA cocultured with 5 1.78 ϫ 10 viridans group streptococci was effectively inhibited. For example, the cell number of MRSA cocultured with cfu 4 5 ϫ 10 of S. sanguinis (ratio of the cell number of MRSA to that of viridans group streptococci, 1:100) increased, within 15 h, from 50 to only cfu (figure 5). On the basis of these results, we conclude that the bactericidal activity of viridans group streptococci is due to H 2 O 2 .
DISCUSSION
Beneficial and harmful effects of H 2 O 2 produced by several bacteria because of alteration of human physiology have been the subject of special investigation. The a-hemolysin of viridans group streptococci, a potential virulence factor, was identified as H 2 O 2 [18] , and streptolysin S and H 2 O 2 synergistically injure vascular endothelial cells [19] ; however, H 2 O 2 produced by lactobacilli may protect pregnant women from vaginosis [7] .
As shown in an accompanying report [15] , viridans group streptococci may prevent MRSA colonization of oral cavities in newborns, and, in the present report, we indicate that the bacteriocin-like activity of viridans group streptococci is the probable cause for such protection. This bacteriocin-like activity was abrogated by the addition of horseradish peroxidase or catalase, and we conclude that the substance possessing the bacteriocin-like activity is H 2 O 2 .
The precise role of H 2 O 2 produced by viridans group streptococci in oral cavities is still under investigation. Ryan and Kleinberg [20] denied that H 2 O 2 has an antagonistic effect on pathogenic bacteria, because H 2 O 2 produced by viridans group streptococci was rapidly degraded by bacteria in the oral cavity, including Neisseria sicca, Haemophilus segnis, Haemophilus parainfluenzae, Actinomyces viscosus, and S. epidermidis (which are all species that use H 2 O 2 ). If so, fortunately, the bacterial composition of oral cavities in newborns (especially very young newborns such as those included in our study and in the accompanying investigation [15] ) is simple compared with that of the oral cavities of adults. Although small amounts of S. epidermidis coexisted with viridans group streptococci, Neisseria species and Haemophilus species usually did not colonize (colonization with Actinomyces was not tested). These situations may prolong H 2 O 2 retention in the microenvironment of the oral cavity. Moreover, it is interesting that bacteria with high levels of catalase activity were not always highly resistant to H 2 O 2 . Catalase activity, with a few exceptions, tends to be inversely proportional to resistance. Exogenously added catalase protected MRSA from the antagonistic effects of H 2 O 2 , but the amounts required were extremely large compared with the amounts of catalase normally associated with MRSA cells. According to these results, studies of the unknown mechanisms controlling susceptibility of H 2 O 2 to decomposition seem to be more important than studies of the mechanisms of activity of decomposition.
Some investigators believed in the importance of an antagonistic effect of H 2 O 2 and performed basic investigations on environmental conditions of H 2 O 2 formation [8, 21] . In our study, viridans group streptococci successfully inhibited MRSA growth even in saliva.
In the present report, we show that H 2 O 2 produced by viridans group streptococci kills MRSA in vitro. However, further studies should be performed to prove that H 2 O 2 kills MRSA in vivo.
